IBDEI0QW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13234,0)
 ;;=462.^^81^829^8
 ;;^UTILITY(U,$J,358.3,13234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13234,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,13234,1,5,0)
 ;;=5^Pharyngitis
 ;;^UTILITY(U,$J,358.3,13234,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,13235,0)
 ;;=477.9^^81^829^9
 ;;^UTILITY(U,$J,358.3,13235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13235,1,4,0)
 ;;=4^477.9
 ;;^UTILITY(U,$J,358.3,13235,1,5,0)
 ;;=5^Rhinitis
 ;;^UTILITY(U,$J,358.3,13235,2)
 ;;=^4955
 ;;^UTILITY(U,$J,358.3,13236,0)
 ;;=461.9^^81^829^10
 ;;^UTILITY(U,$J,358.3,13236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13236,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,13236,1,5,0)
 ;;=5^Sinusitis,Acute
 ;;^UTILITY(U,$J,358.3,13236,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,13237,0)
 ;;=473.9^^81^829^11
 ;;^UTILITY(U,$J,358.3,13237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13237,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,13237,1,5,0)
 ;;=5^Sinusitis,Chronic
 ;;^UTILITY(U,$J,358.3,13237,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,13238,0)
 ;;=373.11^^81^829^12
 ;;^UTILITY(U,$J,358.3,13238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13238,1,4,0)
 ;;=4^373.11
 ;;^UTILITY(U,$J,358.3,13238,1,5,0)
 ;;=5^Stye
 ;;^UTILITY(U,$J,358.3,13238,2)
 ;;=^58510
 ;;^UTILITY(U,$J,358.3,13239,0)
 ;;=784.42^^81^829^3
 ;;^UTILITY(U,$J,358.3,13239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13239,1,4,0)
 ;;=4^784.42
 ;;^UTILITY(U,$J,358.3,13239,1,5,0)
 ;;=5^Hoarseness
 ;;^UTILITY(U,$J,358.3,13239,2)
 ;;=^338283
 ;;^UTILITY(U,$J,358.3,13240,0)
 ;;=380.10^^81^829^4
 ;;^UTILITY(U,$J,358.3,13240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13240,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,13240,1,5,0)
 ;;=5^Infective Otitis Externa, Unspecified
 ;;^UTILITY(U,$J,358.3,13240,2)
 ;;=^62807
 ;;^UTILITY(U,$J,358.3,13241,0)
 ;;=272.1^^81^830^1
 ;;^UTILITY(U,$J,358.3,13241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13241,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,13241,1,5,0)
 ;;=5^Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,13241,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,13242,0)
 ;;=242.90^^81^830^2
 ;;^UTILITY(U,$J,358.3,13242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13242,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,13242,1,5,0)
 ;;=5^Hyperthyroidism w/o Crisis
 ;;^UTILITY(U,$J,358.3,13242,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,13243,0)
 ;;=244.9^^81^830^3
 ;;^UTILITY(U,$J,358.3,13243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13243,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,13243,1,5,0)
 ;;=5^Hypothyroidism
 ;;^UTILITY(U,$J,358.3,13243,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,13244,0)
 ;;=250.01^^81^830^4
 ;;^UTILITY(U,$J,358.3,13244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13244,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,13244,1,5,0)
 ;;=5^DM, Type I
 ;;^UTILITY(U,$J,358.3,13244,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,13245,0)
 ;;=250.00^^81^830^5
 ;;^UTILITY(U,$J,358.3,13245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13245,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,13245,1,5,0)
 ;;=5^DM, Type II
 ;;^UTILITY(U,$J,358.3,13245,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,13246,0)
 ;;=250.02^^81^830^6
 ;;^UTILITY(U,$J,358.3,13246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13246,1,4,0)
 ;;=4^250.02
 ;;^UTILITY(U,$J,358.3,13246,1,5,0)
 ;;=5^DM, Type II Uncontrolled
 ;;^UTILITY(U,$J,358.3,13246,2)
 ;;=^331781
 ;;^UTILITY(U,$J,358.3,13247,0)
 ;;=271.3^^81^830^7
 ;;^UTILITY(U,$J,358.3,13247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13247,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,13247,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,13247,2)
 ;;=^64790
